UnitedHealth, WellPoint Earnings Woes Include Higher Medicare Drug Costs
Executive Summary
UnitedHealth Group and WellPoint both reported last week that unexpectedly high drug costs in their Medicare plans pressured overall earnings during the first quarter
You may also be interested in...
UnitedHealth Plans “Series” Of Part D Formulary Restrictions In 2009
National stand-alone Medicare drug plans co-sponsored by UnitedHealth and AARP will impose new formulary restrictions in major drug categories including cholesterol treatments, proton pump inhibitors and osteoporosis therapies in 2009 to help control costs
UnitedHealth Plans “Series” Of Part D Formulary Restrictions In 2009
National stand-alone Medicare drug plans co-sponsored by UnitedHealth and AARP will impose new formulary restrictions in major drug categories including cholesterol treatments, proton pump inhibitors and osteoporosis therapies in 2009 to help control costs
UnitedHealth Clipped By SNPs: Medicare Chronic Care Plans Too Costly
UnitedHealth Group has stopped marketing its Medicare Advantage chronic special needs plans in major markets in an effort to stem losses from much higher than expected costs this year